I2I
AGN

Insight 2811 Inc’s Allergan plc AGN Stock Holding History

Insight 2811 Inc’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,490
Closed -$285K – 102
2019
Q4 		$285K Hold
1,490
– – 0.19% 69
2019
Q3 		$251K Sell
1,490
-282
-16% -$45.9K 0.18% 72
2019
Q2 		$301K Sell
1,772
-274
-13% -$37.9K 0.22% 69
2019
Q1 		$300K Sell
2,046
-203
-9% -$29.4K 0.23% 70
2018
Q4 		$301K Sell
2,249
-500
-18% -$82K 0.26% 64
2018
Q3 		$524K Sell
2,749
-200
-7% -$36.7K 0.35% 55
2018
Q2 		$492K Buy
2,949
+1,500
+104% +$241K 0.34% 48
2018
Q1 		$244K Buy
+1,449
New +$243K 0.18% 71
2016
Q4 		– Sell
-1,049
Closed -$242K – 91
2016
Q3 		$242K Buy
+1,049
New +$256K 0.15% 80

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Insight 2811 Inc's AGN Position: Q1 2020 in Review

Insight 2811 Inc sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 1,490 shares — an estimated $285K sold.

Insight 2811 Inc first reported a position in AGN in Q3 2016 and held it in 9 quarters. The position peaked at $524K in Q3 2018. 875 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Insight 2811 Inc reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Insight 2811 Inc sold 1,490 Allergan plc shares in Q1 2020, an estimated $285K.
  • Insight 2811 Inc first reported a position in Allergan plc in Q3 2016 and held it in 9 quarters.
  • Insight 2811 Inc's Allergan plc position peaked at $524K in Q3 2018.
  • 875 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Insight 2811 Inc's 13F filing for Q1 2020, filed 5 May 2020.